ID: ALA3113376

Max Phase: Preclinical

Molecular Formula: C16H15N3O3S2

Molecular Weight: 361.45

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=S(=O)(Nc1nccs1)c1ccc(NCc2ccccc2O)cc1

Standard InChI:  InChI=1S/C16H15N3O3S2/c20-15-4-2-1-3-12(15)11-18-13-5-7-14(8-6-13)24(21,22)19-16-17-9-10-23-16/h1-10,18,20H,11H2,(H,17,19)

Standard InChI Key:  QZMVRYKARIARSL-UHFFFAOYSA-N

Associated Targets(Human)

Arachidonate 12-lipoxygenase 3262 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 361.45Molecular Weight (Monoisotopic): 361.0555AlogP: 3.26#Rotatable Bonds: 6
Polar Surface Area: 91.32Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 6.92CX Basic pKa: 1.95CX LogP: 2.70CX LogD: 2.22
Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.63Np Likeness Score: -1.70

References

1. Luci DK, Jameson JB, Yasgar A, Diaz G, Joshi N, Kantz A, Markham K, Perry S, Kuhn N, Yeung J, Kerns EH, Schultz L, Holinstat M, Nadler JL, Taylor-Fishwick DA, Jadhav A, Simeonov A, Holman TR, Maloney DJ..  (2014)  Synthesis and structure-activity relationship studies of 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase.,  57  (2): [PMID:24393039] [10.1021/jm4016476]

Source